8月14日,由复宏汉霖自主研制的首个国产曲妥珠单抗汉曲优®(HLX02,欧盟商品名:Zercepac®)获国家药品监督管理局(National Medical Products Administration, NMPA)批准上市,用于治疗HER2阳性的早期乳腺癌、转移性乳腺癌及转移性胃癌,涵盖原研曲妥珠单抗在中国...
8月14日,由复宏汉霖自主研制的首个国产曲妥珠单抗汉曲优®(HLX02,欧盟商品名:Zercepac®)获国家药品监督管理局(National Medical Products Administration, NMPA)批准上市,用于治疗HER2阳性的早期乳腺癌、转移性乳腺癌及转移性胃癌,涵盖原研曲妥珠单抗在中国已获批的所有适应症,为我国抗HER2领域提供了国际品质的治疗...
)获国家药品监督管理局(National Medical Products Administration, NMPA)批准上市,用于治疗HER2阳性的早期乳腺癌、转移性乳腺癌及转移性胃癌,涵盖原研曲妥珠单抗在中国已获批的所有适应症,为我国抗HER2领域提供了国际品质的治疗新选择。此前该药品已获欧盟委员会(European Commission,EC)批准上市,成为首个登陆欧洲的“中国...
8月14日,由复宏汉霖自主研制的首个国产曲妥珠单抗汉曲优®(HLX02,欧盟商品名:Zercepac®)获国家药品监督管理局(National Medical Products Administration, NMPA)批准上市,用于治疗HER2阳性的早期乳腺癌、转移性乳腺癌及转移性胃癌,涵盖原研曲妥珠单抗在中国已获批的所有适应症,为我国抗HER2领域提供了国际品质的治疗...
Google Share on Facebook Medical AcronymDefinition HER2Human EGF (Epidermal Growth Factor) Receptor 2(oncology) Copyright 1988-2018AcronymFinder.com, All rights reserved. Suggest new definition Want to thank TFD for its existence?Tell a friend about us, add a link to this page, or visitthe web...
A little bit of background of the trial, we know first-line doublet chemotherapy with platinum/fluoropyrimidine agents is standard-of-care in first-line therapy in HER2-negative disease and low or absent PD-L1 expression...
HER2-low breast cancer (BC) is currently an area of active interest. This study evaluated the impact of low expression of HER2 on survival outcomes in HER2-negative non-metastatic breast cancer (BC). Patients with HER2-negative non-metastatic BC from 6 c
ResultsThe positive expression of KIF20A was in the nucleus, forming brown-yellow particles. In HER2-positive breast cancer tissues, the positive high expression rate of KIF20A is 57.3%, while it is mainly low or no expression in the adjacent tissues. The high expression of KIF20A is signific...
and T-DXd more as a later line therapy simply because there's more data.I think it's more evidence-based.But if I have a patient who had hormone receptor positive disease that becomes negative or really low,and...
For women of childbearing age, a negative pregnancy test and use of adequate contraception were also required. Patients were excluded if they had the following: bilateral invasive or metastatic breast cancer, a pre-existing neurotoxicity grade X2 (based on the National Cancer Institute-Common ...